Filing Flows

Filing Flows › Core Laboratories (CLB) › Q4 2025

Core Laboratories (CLB) Q4 2025 earnings results (fourth quarter 2025)

10-K filed Mar 23, 2026

Core Laboratories (CLB) reported revenue of $138M for the fourth quarter 2025 (Q4 2025), +7% from a year earlier and +3% from the quarter before. Operating margin was 11.5%, net earnings $4.9M (3.6% of revenue).

Revenue$138M
Year over year+7%
Quarter over quarter+3%
Operating margin11.5%
Net earnings$4.9M

Core Laboratories, Q4 2025: revenue $138M (+7% year over year), operating margin 11.5%, net earnings $4.9M, operating cash flow $7.9M. The chart follows the revenue to costs, profit and cash.

Q4 2025AmountQ/QY/Y
Revenue$138M+3%+7%
Operating profit$15.8M-24%+12%
Net earnings$4.9M-65%-33%
Operating cash flow$7.9M-7%-61%
Free cash flow$5.0M-23%-71%

What changed

Revenue was $138.3M in Q4 2025, up 7% year over year and up 3% from the previous quarter. Service was the largest line at 77% of revenue.

Operating profit was $15.8M, a 11.5% margin (up 0.5 points year over year). Of the extra revenue versus a year earlier, 18% reached operating profit, above the 11% margin then. Total costs grew 6% against revenue growth of 7%. The fastest-growing cost line was General & admin (+17%). Net earnings were $4.9M, down 33% year over year. The effective tax rate was 61.2%.

Operating cash flow was $7.9M (down 61% year over year), 155% of net income including minority interests. Non-cash charges added back $3.7M of depreciation and amortization and $1.1M of share-based compensation. Working capital and other items used $2.0M. Capital expenditures of $2.9M left free cash flow of $5.0M.

Questions

What was Core Laboratories' revenue in the fourth quarter 2025?

Core Laboratories (CLB) reported revenue of $138M for the fourth quarter 2025 (Q4 2025), +7% from a year earlier and +3% from the quarter before.

Was Core Laboratories profitable in the fourth quarter 2025?

Operating profit was $15.8M (11.5% of revenue) and net earnings $4.9M.

Open the interactive Sankey →

Source: Core Laboratories 10-K on SEC EDGAR.